 | • レポートコード：20QY06-01910 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、コロイド（血液血漿）のグローバル市場について種類別（天然系コロイド（血漿）、合成系コロイド（血漿））、用途別（広範囲火傷、大量血液または血漿喪失、血液量減少性ショック、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・コロイド（血液血漿）市場の概要 ・世界の主要地域別コロイド（血液血漿）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のコロイド（血液血漿）市場規模2015-2026：種類別（天然系コロイド（血漿）、合成系コロイド（血漿）） ・世界のコロイド（血液血漿）市場規模2015-2026：用途別（広範囲火傷、大量血液または血漿喪失、血液量減少性ショック、その他） ・コロイド（血液血漿）の北米市場規模2015-2020 ・コロイド（血液血漿）のヨーロッパ市場規模2015-2020 ・コロイド（血液血漿）の中国市場規模2015-2020 ・コロイド（血液血漿）の日本市場規模2015-2020 ・コロイド（血液血漿）の東南アジア市場規模2015-2020 ・コロイド（血液血漿）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （CSL Behring、Baxter、Grifols、Octapharma、Kedrion、Shanghai Raas、CTBB、Hualan Bio、Rongsheng Pharmaceutical、Boya Rongsheng、B. Braun Medical、Fresenius Kabi、HOSPIRA、Axa parenterals、Fresenius Kabi(China)、CR Double-Crane、Kelun Group、Shandong Qidu Pharmaceutical、Shandong Hualu Pharmaceutical、Minsheng Pharma、Kanglepharm） ・コロイド（血液血漿）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・コロイド（血液血漿）の市場動向・機会・課題 ・調査の結論 |
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
The global colloids (blood plasma) industry is mature. The production of synthetic colloids increase from 42.03 Million Units in 2010 to 53.43 Million Units in 2015, with an average growth rate of more than 5.42 %.
Market Analysis and Insights: Global Colloids (Blood Plasma) Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Colloids (Blood Plasma) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Colloids (Blood Plasma) industry.
Based on our recent survey, we have several different scenarios about the Colloids (Blood Plasma) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 428.6 million in 2019. The market size of Colloids (Blood Plasma) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Colloids (Blood Plasma) Scope and Market Size
The global Colloids (Blood Plasma) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Colloids (Blood Plasma) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Colloids (Blood Plasma) market is segmented into
Natural Type Colloids (Blood Plasma)
Synthetic Type Colloids (Blood Plasma)
Segment by Application, the Colloids (Blood Plasma) market is segmented into
Extensive Burns
Massive Blood or Plasma Loss
Hypovolemic Shock
Others
The Colloids (Blood Plasma) market is analysed and market size information is provided by regions (countries). Segment by Application, the Colloids (Blood Plasma) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Colloids (Blood Plasma) Market Share Analysis
Colloids (Blood Plasma) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Colloids (Blood Plasma) business, the date to enter into the Colloids (Blood Plasma) market, Colloids (Blood Plasma) product introduction, recent developments, etc.
The major vendors covered:
CSL Behring
Baxter
Grifols
Octapharma
Kedrion
Shanghai Raas
CTBB
Hualan Bio
Rongsheng Pharmaceutical
Boya Rongsheng
B. Braun Medical
Fresenius Kabi
HOSPIRA
Axa parenterals
Fresenius Kabi(China)
CR Double-Crane
Kelun Group
Shandong Qidu Pharmaceutical
Shandong Hualu Pharmaceutical
Minsheng Pharma
Kanglepharm
1 Colloids (Blood Plasma) Market Overview
1.1 Colloids (Blood Plasma) Product Scope
1.2 Colloids (Blood Plasma) Segment by Type
1.2.1 Global Colloids (Blood Plasma) Sales by Type (2020-2026)
1.2.2 Natural Type Colloids (Blood Plasma)
1.2.3 Synthetic Type Colloids (Blood Plasma)
1.3 Colloids (Blood Plasma) Segment by Application
1.3.1 Global Colloids (Blood Plasma) Sales Comparison by Application (2020-2026)
1.3.2 Extensive Burns
1.3.3 Massive Blood or Plasma Loss
1.3.4 Hypovolemic Shock
1.3.5 Others
1.4 Colloids (Blood Plasma) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Colloids (Blood Plasma) Sales Growth Rate (2015-2026)
1.4.2 Global Colloids (Blood Plasma) Revenue and Growth Rate (2015-2026)
1.4.3 Global Colloids (Blood Plasma) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Colloids (Blood Plasma) Industry Impact
1.5.1 How the Covid-19 is Affecting the Colloids (Blood Plasma) Industry
1.5.1.1 Colloids (Blood Plasma) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Colloids (Blood Plasma) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Colloids (Blood Plasma) Players to Combat Covid-19 Impact
2 Colloids (Blood Plasma) Estimate and Forecast by Region
2.1 Global Colloids (Blood Plasma) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Colloids (Blood Plasma) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Colloids (Blood Plasma) Sales Market Share by Region (2015-2020)
2.2.2 Global Colloids (Blood Plasma) Revenue Market Share by Region (2015-2020)
2.3 Global Colloids (Blood Plasma) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Colloids (Blood Plasma) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Colloids (Blood Plasma) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Colloids (Blood Plasma) Estimates and Projections (2015-2026)
2.4.2 Europe Colloids (Blood Plasma) Estimates and Projections (2015-2026)
2.4.3 China Colloids (Blood Plasma) Estimates and Projections (2015-2026)
2.4.4 Japan Colloids (Blood Plasma) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Colloids (Blood Plasma) Estimates and Projections (2015-2026)
2.4.6 India Colloids (Blood Plasma) Estimates and Projections (2015-2026)
3 Global Colloids (Blood Plasma) Competition Landscape by Players
3.1 Global Top Colloids (Blood Plasma) Players by Sales (2015-2020)
3.2 Global Top Colloids (Blood Plasma) Players by Revenue (2015-2020)
3.3 Global Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colloids (Blood Plasma) as of 2019)
3.4 Global Colloids (Blood Plasma) Average Price by Company (2015-2020)
3.5 Manufacturers Colloids (Blood Plasma) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Colloids (Blood Plasma) Players (Opinion Leaders)
4 Global Colloids (Blood Plasma) Market Size by Type
4.1 Global Colloids (Blood Plasma) Historic Market Review by Type (2015-2020)
4.1.1 Global Colloids (Blood Plasma) Sales Market Share by Type (2015-2020)
4.1.2 Global Colloids (Blood Plasma) Revenue Market Share by Type (2015-2020)
4.1.3 Global Colloids (Blood Plasma) Price by Type (2014-2020)
4.2 Global Colloids (Blood Plasma) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Colloids (Blood Plasma) Sales Forecast by Type (2021-2026)
4.2.2 Global Colloids (Blood Plasma) Revenue Forecast by Type (2021-2026)
4.2.3 Global Colloids (Blood Plasma) Price Forecast by Type (2021-2026)
5 Global Colloids (Blood Plasma) Market Size by Application
5.1 Global Colloids (Blood Plasma) Historic Market Review by Application (2015-2020)
5.1.1 Global Colloids (Blood Plasma) Sales Market Share by Application (2015-2020)
5.1.2 Global Colloids (Blood Plasma) Revenue Market Share by Application (2015-2020)
5.1.3 Global Colloids (Blood Plasma) Price by Application (2015-2020)
5.2 Global Colloids (Blood Plasma) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Colloids (Blood Plasma) Sales Forecast by Application (2021-2026)
5.2.2 Global Colloids (Blood Plasma) Revenue Forecast by Application (2021-2026)
5.2.3 Global Colloids (Blood Plasma) Price Forecast by Application (2021-2026)
3 North America Colloids (Blood Plasma) Market Facts & Figures
3.2 North America Colloids (Blood Plasma) Sales Market Share by Company (2015-2020)
3.3 North America Colloids (Blood Plasma) Sales Market Share by Type (2015-2020)
3.4 North America Colloids (Blood Plasma) Sales Market Share by Application (2015-2020)
4 Europe Colloids (Blood Plasma) Market Facts & Figures
4.2 Europe Colloids (Blood Plasma) Sales Market Share by Company (2015-2020)
4.3 Europe Colloids (Blood Plasma) Sales Market Share by Type (2015-2020)
4.4 Europe Colloids (Blood Plasma) Sales Market Share by Application (2015-2020)
5 China Colloids (Blood Plasma) Market Facts & Figures
5.2 China Colloids (Blood Plasma) Sales Market Share by Company (2015-2020)
5.3 China Colloids (Blood Plasma) Sales Market Share by Type (2015-2020)
5.4 China Colloids (Blood Plasma) Sales Market Share by Application (2015-2020)
6 Japan Colloids (Blood Plasma) Market Facts & Figures
6.2 Japan Colloids (Blood Plasma) Sales Market Share by Company (2015-2020)
6.3 Japan Colloids (Blood Plasma) Sales Market Share by Type (2015-2020)
6.4 Japan Colloids (Blood Plasma) Sales Market Share by Application (2015-2020)
7 Southeast Asia Colloids (Blood Plasma) Market Facts & Figures
7.2 Southeast Asia Colloids (Blood Plasma) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Colloids (Blood Plasma) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Colloids (Blood Plasma) Sales Market Share by Application (2015-2020)
8 India Colloids (Blood Plasma) Market Facts & Figures
8.2 India Colloids (Blood Plasma) Sales Market Share by Company (2015-2020)
8.3 India Colloids (Blood Plasma) Sales Market Share by Type (2015-2020)
8.4 India Colloids (Blood Plasma) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Colloids (Blood Plasma) Business
12.1 CSL Behring
12.1.1 CSL Behring Colloids (Blood Plasma) Corporation Information
12.1.2 CSL Behring Colloids (Blood Plasma) Business Overview and Total Revenue
12.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 CSL Behring Colloids (Blood Plasma) Products Offered
12.1.5 CSL Behring Recent Development
12.2 Baxter
12.2.1 Baxter Colloids (Blood Plasma) Corporation Information
12.2.2 Baxter Colloids (Blood Plasma) Business Overview and Total Revenue
12.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Baxter Colloids (Blood Plasma) Products Offered
12.2.5 Baxter Recent Development
12.3 Grifols
12.3.1 Grifols Colloids (Blood Plasma) Corporation Information
12.3.2 Grifols Colloids (Blood Plasma) Business Overview and Total Revenue
12.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Grifols Colloids (Blood Plasma) Products Offered
12.3.5 Grifols Recent Development
12.4 Octapharma
12.4.1 Octapharma Colloids (Blood Plasma) Corporation Information
12.4.2 Octapharma Colloids (Blood Plasma) Business Overview and Total Revenue
12.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Octapharma Colloids (Blood Plasma) Products Offered
12.4.5 Octapharma Recent Development
12.5 Kedrion
12.5.1 Kedrion Colloids (Blood Plasma) Corporation Information
12.5.2 Kedrion Colloids (Blood Plasma) Business Overview and Total Revenue
12.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Kedrion Colloids (Blood Plasma) Products Offered
12.5.5 Kedrion Recent Development
12.6 Shanghai Raas
12.6.1 Shanghai Raas Colloids (Blood Plasma) Corporation Information
12.6.2 Shanghai Raas Colloids (Blood Plasma) Business Overview and Total Revenue
12.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Shanghai Raas Colloids (Blood Plasma) Products Offered
12.6.5 Shanghai Raas Recent Development
12.7 CTBB
12.7.1 CTBB Colloids (Blood Plasma) Corporation Information
12.7.2 CTBB Colloids (Blood Plasma) Business Overview and Total Revenue
12.7.3 CTBB Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 CTBB Colloids (Blood Plasma) Products Offered
12.7.5 CTBB Recent Development
12.8 Hualan Bio
12.8.1 Hualan Bio Colloids (Blood Plasma) Corporation Information
12.8.2 Hualan Bio Colloids (Blood Plasma) Business Overview and Total Revenue
12.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Hualan Bio Colloids (Blood Plasma) Products Offered
12.8.5 Hualan Bio Recent Development
12.9 Rongsheng Pharmaceutical
12.9.1 Rongsheng Pharmaceutical Colloids (Blood Plasma) Corporation Information
12.9.2 Rongsheng Pharmaceutical Colloids (Blood Plasma) Business Overview and Total Revenue
12.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Products Offered
12.9.5 Rongsheng Pharmaceutical Recent Development
12.10 Boya Rongsheng
12.10.1 Boya Rongsheng Colloids (Blood Plasma) Corporation Information
12.10.2 Boya Rongsheng Colloids (Blood Plasma) Business Overview and Total Revenue
12.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Boya Rongsheng Colloids (Blood Plasma) Products Offered
12.10.5 Boya Rongsheng Recent Development
12.11 B. Braun Medical
12.11.1 B. Braun Medical Colloids (Blood Plasma) Corporation Information
12.11.2 B. Braun Medical Colloids (Blood Plasma) Business Overview and Total Revenue
12.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 B. Braun Medical Colloids (Blood Plasma) Products Offered
12.11.5 B. Braun Medical Recent Development
12.12 Fresenius Kabi
12.12.1 Fresenius Kabi Colloids (Blood Plasma) Corporation Information
12.12.2 Fresenius Kabi Colloids (Blood Plasma) Business Overview and Total Revenue
12.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Fresenius Kabi Colloids (Blood Plasma) Products Offered
12.12.5 Fresenius Kabi Recent Development
12.13 HOSPIRA
12.13.1 HOSPIRA Colloids (Blood Plasma) Corporation Information
12.13.2 HOSPIRA Colloids (Blood Plasma) Business Overview and Total Revenue
12.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.13.4 HOSPIRA Colloids (Blood Plasma) Products Offered
12.13.5 HOSPIRA Recent Development
12.14 Axa parenterals
12.14.1 Axa parenterals Colloids (Blood Plasma) Corporation Information
12.14.2 Axa parenterals Colloids (Blood Plasma) Business Overview and Total Revenue
12.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Axa parenterals Colloids (Blood Plasma) Products Offered
12.14.5 Axa parenterals Recent Development
12.15 Fresenius Kabi(China)
12.15.1 Fresenius Kabi(China) Colloids (Blood Plasma) Corporation Information
12.15.2 Fresenius Kabi(China) Colloids (Blood Plasma) Business Overview and Total Revenue
12.15.3 Fresenius Kabi(China) Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Fresenius Kabi(China) Colloids (Blood Plasma) Products Offered
12.15.5 Fresenius Kabi(China) Recent Development
12.16 CR Double-Crane
12.16.1 CR Double-Crane Colloids (Blood Plasma) Corporation Information
12.16.2 CR Double-Crane Colloids (Blood Plasma) Business Overview and Total Revenue
12.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.16.4 CR Double-Crane Colloids (Blood Plasma) Products Offered
12.16.5 CR Double-Crane Recent Development
12.17 Kelun Group
12.17.1 Kelun Group Colloids (Blood Plasma) Corporation Information
12.17.2 Kelun Group Colloids (Blood Plasma) Business Overview and Total Revenue
12.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Kelun Group Colloids (Blood Plasma) Products Offered
12.17.5 Kelun Group Recent Development
12.18 Shandong Qidu Pharmaceutical
12.18.1 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Corporation Information
12.18.2 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Business Overview and Total Revenue
12.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Products Offered
12.18.5 Shandong Qidu Pharmaceutical Recent Development
12.19 Shandong Hualu Pharmaceutical
12.19.1 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Corporation Information
12.19.2 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Business Overview and Total Revenue
12.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Products Offered
12.19.5 Shandong Hualu Pharmaceutical Recent Development
12.20 Minsheng Pharma
12.20.1 Minsheng Pharma Colloids (Blood Plasma) Corporation Information
12.20.2 Minsheng Pharma Colloids (Blood Plasma) Business Overview and Total Revenue
12.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Minsheng Pharma Colloids (Blood Plasma) Products Offered
12.20.5 Minsheng Pharma Recent Development
12.21 Kanglepharm
12.21.1 Kanglepharm Colloids (Blood Plasma) Corporation Information
12.21.2 Kanglepharm Colloids (Blood Plasma) Business Overview and Total Revenue
12.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Kanglepharm Colloids (Blood Plasma) Products Offered
12.21.5 Kanglepharm Recent Development
13 Colloids (Blood Plasma) Manufacturing Cost Analysis
13.1 Colloids (Blood Plasma) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Colloids (Blood Plasma)
13.4 Colloids (Blood Plasma) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Colloids (Blood Plasma) Distributors List
14.3 Colloids (Blood Plasma) Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Colloids (Blood Plasma) Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Colloids (Blood Plasma) Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Colloids (Blood Plasma) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Colloids (Blood Plasma) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Colloids (Blood Plasma) Players to Combat Covid-19 Impact
Table 8. Global Market Colloids (Blood Plasma) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Colloids (Blood Plasma) Sales (MT) by Region (2015-2020)
Table 10. Global Colloids (Blood Plasma) Sales Market Share by Region (2015-2020)
Table 11. Global Colloids (Blood Plasma) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Colloids (Blood Plasma) Revenue Share by Region (2015-2020)
Table 13. Global Colloids (Blood Plasma) Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Colloids (Blood Plasma) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Colloids (Blood Plasma) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Colloids (Blood Plasma) Revenue Share Forecast by Region (2021-2026)
Table 17. Global Colloids (Blood Plasma) (MT) of Key Companies (2015-2020)
Table 18. Global Colloids (Blood Plasma) Sales Share by Company (2015-2020)
Table 19. Global Colloids (Blood Plasma) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Colloids (Blood Plasma) Revenue Share by Company (2015-2020)
Table 21. Global Colloids (Blood Plasma) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colloids (Blood Plasma) as of 2019)
Table 22. Global Colloids (Blood Plasma) Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Colloids (Blood Plasma) Manufacturing Sites and Area Served
Table 24. Manufacturers Colloids (Blood Plasma) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Colloids (Blood Plasma) Players
Table 27. Global Colloids (Blood Plasma) Sales (MT) by Type (2015-2020)
Table 28. Global Colloids (Blood Plasma) Sales Share by Type (2015-2020)
Table 29. Global Colloids (Blood Plasma) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Colloids (Blood Plasma) Price (MT) by Type (2015-2020)
Table 31. Global Colloids (Blood Plasma) Sales Share by Type (2021-2026)
Table 32. Global Colloids (Blood Plasma) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Colloids (Blood Plasma) Revenue Share by Type (2021-2026)
Table 34. Global Colloids (Blood Plasma) Price (MT) by Type (2021-2026)
Table 35. Global Colloids (Blood Plasma) Sales (MT) by Application (2015-2020)
Table 36. Global Colloids (Blood Plasma) Sales Share by Application (2015-2020)
Table 37. Global Colloids (Blood Plasma) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Colloids (Blood Plasma) Price (MT) by Application (2015-2020)
Table 39. Global Colloids (Blood Plasma) Sales (MT) by Application (2021-2026)
Table 40. Global Colloids (Blood Plasma) Sales Share by Application (2021-2026)
Table 41. Global Colloids (Blood Plasma) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Colloids (Blood Plasma) Revenue Share by Application (2021-2026)
Table 43. Global Colloids (Blood Plasma) Price (MT) by Application (2021-2026)
Table 44. United States Colloids (Blood Plasma) Sales (MT) by Company (2015-2020)
Table 45. United States Colloids (Blood Plasma) Sales Market Share by Company (2015-2020)
Table 46. United States Colloids (Blood Plasma) Sales (MT) by Type (2015-2020)
Table 47. United States Colloids (Blood Plasma) Sales Market Share by Type (2015-2020)
Table 48. United States Colloids (Blood Plasma) Sales (MT) by Application (2015-2020)
Table 49. United States Colloids (Blood Plasma) Sales Market Share by Application (2015-2020)
Table 50. Europe Colloids (Blood Plasma) Sales (MT) by Company (2015-2020)
Table 51. Europe Colloids (Blood Plasma) Sales Market Share by Company (2015-2020)
Table 52. Europe Colloids (Blood Plasma) Sales (MT) by Type (2015-2020)
Table 53. Europe Colloids (Blood Plasma) Sales Market Share by Type (2015-2020)
Table 54. Europe Colloids (Blood Plasma) Sales (MT) by Application (2015-2020)
Table 55. Europe Colloids (Blood Plasma) Sales Market Share by Type (2015-2020)
Table 56. China Colloids (Blood Plasma) Sales (MT) by Company (2015-2020)
Table 57. China Colloids (Blood Plasma) Sales Market Share by Company (2015-2020)
Table 58. China Colloids (Blood Plasma) Sales (MT) by Type (2015-2020)
Table 59. China Colloids (Blood Plasma) Sales Market Share by Type (2015-2020)
Table 60. China Colloids (Blood Plasma) Sales (MT) by Application (2015-2020)
Table 61. China Colloids (Blood Plasma) Sales Market Share by Application (2015-2020)
Table 62. Japan Colloids (Blood Plasma) Sales (MT) by Company (2015-2020)
Table 63. Japan Colloids (Blood Plasma) Sales Market Share by Company (2015-2020)
Table 64. Japan Colloids (Blood Plasma) Sales (MT) by Type (2015-2020)
Table 65. Japan Colloids (Blood Plasma) Sales Market Share by Type (2015-2020)
Table 66. Japan Colloids (Blood Plasma) Sales (MT) by Application (2015-2020)
Table 67. Japan Colloids (Blood Plasma) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Colloids (Blood Plasma) Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Colloids (Blood Plasma) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Colloids (Blood Plasma) Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Colloids (Blood Plasma) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Colloids (Blood Plasma) Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Colloids (Blood Plasma) Sales Market Share by Application (2015-2020)
Table 74. India Colloids (Blood Plasma) Sales (MT) by Company (2015-2020)
Table 75. India Colloids (Blood Plasma) Sales Market Share by Company (2015-2020)
Table 76. India Colloids (Blood Plasma) Sales (MT) by Type (2015-2020)
Table 77. India Colloids (Blood Plasma) Sales Market Share by Type (2015-2020)
Table 78. India Colloids (Blood Plasma) Sales (MT) by Application (2015-2020)
Table 79. India Colloids (Blood Plasma) Sales Market Share by Application (2015-2020)
Table 80. CSL Behring Corporation Information
Table 81. CSL Behring Description and Business Overview
Table 82. CSL Behring Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. CSL Behring Colloids (Blood Plasma) Product
Table 84. CSL Behring Recent Development
Table 85. Baxter Corporation Information
Table 86. Baxter Description and Business Overview
Table 87. Baxter Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Baxter Colloids (Blood Plasma) Product
Table 89. Baxter Recent Development
Table 90. Grifols Corporation Information
Table 91. Grifols Description and Business Overview
Table 92. Grifols Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Grifols Colloids (Blood Plasma) Product
Table 94. Grifols Recent Development
Table 95. Octapharma Corporation Information
Table 96. Octapharma Description and Business Overview
Table 97. Octapharma Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Octapharma Colloids (Blood Plasma) Product
Table 99. Octapharma Recent Development
Table 100. Kedrion Corporation Information
Table 101. Kedrion Description and Business Overview
Table 102. Kedrion Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Kedrion Colloids (Blood Plasma) Product
Table 104. Kedrion Recent Development
Table 105. Shanghai Raas Corporation Information
Table 106. Shanghai Raas Description and Business Overview
Table 107. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Shanghai Raas Colloids (Blood Plasma) Product
Table 109. Shanghai Raas Recent Development
Table 110. CTBB Corporation Information
Table 111. CTBB Description and Business Overview
Table 112. CTBB Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. CTBB Colloids (Blood Plasma) Product
Table 114. CTBB Recent Development
Table 115. Hualan Bio Corporation Information
Table 116. Hualan Bio Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Hualan Bio Description and Business Overview
Table 118. Hualan Bio Colloids (Blood Plasma) Product
Table 119. Hualan Bio Recent Development
Table 120. Rongsheng Pharmaceutical Corporation Information
Table 121. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Rongsheng Pharmaceutical Description and Business Overview
Table 123. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product
Table 124. Rongsheng Pharmaceutical Recent Development
Table 125. Boya Rongsheng Corporation Information
Table 126. Boya Rongsheng Description and Business Overview
Table 127. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. Boya Rongsheng Colloids (Blood Plasma) Product
Table 129. Boya Rongsheng Recent Development
Table 130. B. Braun Medical Corporation Information
Table 131. B. Braun Medical Description and Business Overview
Table 132. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. B. Braun Medical Colloids (Blood Plasma) Product
Table 134. B. Braun Medical Recent Development
Table 135. Fresenius Kabi Corporation Information
Table 136. Fresenius Kabi Description and Business Overview
Table 137. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 138. Fresenius Kabi Colloids (Blood Plasma) Product
Table 139. Fresenius Kabi Recent Development
Table 140. HOSPIRA Corporation Information
Table 141. HOSPIRA Description and Business Overview
Table 142. HOSPIRA Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 143. HOSPIRA Colloids (Blood Plasma) Product
Table 144. HOSPIRA Recent Development
Table 145. Axa parenterals Corporation Information
Table 146. Axa parenterals Description and Business Overview
Table 147. Axa parenterals Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 148. Axa parenterals Colloids (Blood Plasma) Product
Table 149. Axa parenterals Recent Development
Table 150. Fresenius Kabi(China) Corporation Information
Table 151. Fresenius Kabi(China) Description and Business Overview
Table 152. Fresenius Kabi(China) Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 153. Fresenius Kabi(China) Colloids (Blood Plasma) Product
Table 154. Fresenius Kabi(China) Recent Development
Table 155. CR Double-Crane Corporation Information
Table 156. CR Double-Crane Description and Business Overview
Table 157. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 158. CR Double-Crane Colloids (Blood Plasma) Product
Table 159. CR Double-Crane Recent Development
Table 160. Kelun Group Corporation Information
Table 161. Kelun Group Description and Business Overview
Table 162. Kelun Group Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 163. Kelun Group Colloids (Blood Plasma) Product
Table 164. Kelun Group Recent Development
Table 165. Shandong Qidu Pharmaceutical Corporation Information
Table 166. Shandong Qidu Pharmaceutical Description and Business Overview
Table 167. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 168. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product
Table 169. Shandong Qidu Pharmaceutical Recent Development
Table 170. Shandong Hualu Pharmaceutical Corporation Information
Table 171. Shandong Hualu Pharmaceutical Description and Business Overview
Table 172. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 173. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product
Table 174. Shandong Hualu Pharmaceutical Recent Development
Table 175. Minsheng Pharma Corporation Information
Table 176. Minsheng Pharma Description and Business Overview
Table 177. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 178. Minsheng Pharma Colloids (Blood Plasma) Product
Table 179. Minsheng Pharma Recent Development
Table . Kanglepharm Corporation Information
Table . Kanglepharm Description and Business Overview
Table . Kanglepharm Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Kanglepharm Colloids (Blood Plasma) Product
Table . Kanglepharm Recent Development
Table 185. Production Base and Market Concentration Rate of Raw Material
Table 186. Key Suppliers of Raw Materials
Table 187. Colloids (Blood Plasma) Distributors List
Table 188. Colloids (Blood Plasma) Customers List
Table 189. Market Key Trends
Table 190. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 191. Key Challenges
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Colloids (Blood Plasma) Product Picture
Figure 2. Global Colloids (Blood Plasma) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Colloids (Blood Plasma) Market Share by Application in 2020 & 2026
Figure 6. Extensive Burns Examples
Figure 7. Massive Blood or Plasma Loss Examples
Figure 8. Hypovolemic Shock Examples
Figure 9. Others Examples
Figure 10. Global Colloids (Blood Plasma) Sales (MT) Growth Rate (2015-2026)
Figure 11. Global Colloids (Blood Plasma) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Colloids (Blood Plasma) Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 13. Global Colloids (Blood Plasma) Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Colloids (Blood Plasma) Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Colloids (Blood Plasma) Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Colloids (Blood Plasma) Sales (MT) Growth Rate (2015-2026)
Figure 17. Europe Colloids (Blood Plasma) Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Colloids (Blood Plasma) Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Colloids (Blood Plasma) Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Colloids (Blood Plasma) Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Colloids (Blood Plasma) Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Colloids (Blood Plasma) Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Colloids (Blood Plasma) Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Colloids (Blood Plasma) Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Colloids (Blood Plasma) Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Colloids (Blood Plasma) Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Colloids (Blood Plasma) Players Market Share by Revenue in Colloids (Blood Plasma) 2015 & 2019
Figure 28. Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Colloids (Blood Plasma) Revenue Share by Type (2015-2020)
Figure 30. Global Colloids (Blood Plasma) Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Colloids (Blood Plasma) Revenue Share by Application (2015-2020)
Figure 32. Global Colloids (Blood Plasma) Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Colloids (Blood Plasma) Sales Market Share by Type in 2019
Figure 34. United States Colloids (Blood Plasma) Sales Market Share by Type in 2019
Figure 35. Europe Colloids (Blood Plasma) Sales Market Share by Company in 2019
Figure 36. Europe Colloids (Blood Plasma) Sales Market Share by Type in 2019
Figure 37. Europe Colloids (Blood Plasma) Sales Market Share by Application in 2019
Figure 38. China Colloids (Blood Plasma) Sales Market Share by Company in 2019
Figure 39. China Colloids (Blood Plasma) Sales Market Share by Type in 2019
Figure 40. China Colloids (Blood Plasma) Sales Market Share by Application in 2019
Figure 41. Japan Colloids (Blood Plasma) Sales Market Share by Company in 2019
Figure 42. Japan Colloids (Blood Plasma) Sales Market Share by Type in 2019
Figure 43. Japan Colloids (Blood Plasma) Sales Market Share by Application in 2019
Figure 44. Southeast Asia Colloids (Blood Plasma) Sales Market Share by Company in 2019
Figure 45. Southeast Asia Colloids (Blood Plasma) Sales Market Share by Type in 2019
Figure 46. Southeast Asia Colloids (Blood Plasma) Sales Market Share by Application in 2019
Figure 47. India Colloids (Blood Plasma) Sales Market Share by Company in 2019
Figure 48. India Colloids (Blood Plasma) Sales Market Share by Type in 2019
Figure 49. India Colloids (Blood Plasma) Sales Market Share by Application in 2019
Figure 50. CSL Behring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Kedrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Shanghai Raas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. CTBB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Rongsheng Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Boya Rongsheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. B. Braun Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. HOSPIRA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Axa parenterals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Fresenius Kabi(China) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. CR Double-Crane Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Kelun Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Shandong Qidu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Shandong Hualu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Minsheng Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Kanglepharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Key Raw Materials Price Trend
Figure 72. Manufacturing Cost Structure of Colloids (Blood Plasma)
Figure 73. Manufacturing Process Analysis of Colloids (Blood Plasma)
Figure 74. Colloids (Blood Plasma) Industrial Chain Analysis
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Porter's Five Forces Analysis
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
コロイド（血液血漿）の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Colloids (Blood Plasma) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of -2.4% in the forecast period of 2020 to 2025 and will expected to reach USD 400.3 million by 2025, from USD 441 million in 2019. The Colloid…- 血漿用フリーザーの世界市場レポート2020 Market Analysis and Insights: Global Blood Plasma Freezers Market The global Blood Plasma Freezers market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Blood Plasma Freezers Scope and Market Size The global Bl…
- 血漿誘導体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Blood Plasma Derivatives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 38210 million by 2025, from USD 30860 million in 2019. The Blood Plasma …
- 採血用品の世界市場レポート2020 Market Analysis and Insights: Global Blood Collection Products Market The global Blood Collection Products market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Blood Collection Products Scope and Market Size T…
- プラズマエキスパンダーの世界市場レポート2020 Plasma expanders are agents that have high molecular weight and that boost the plasma volume by increasing the osmotic pressure. After administration, plasma expanders remain for an enough time to restore the volume of the circulatory fluid by increasing the osmotic pressure. Increased government fu…